Print Page  Close Window


SEC Filings

S-1/A
OREXIGEN THERAPEUTICS, INC. filed this Form S-1/A on 02/16/2007
Entire Document
 
Table of Contents

                                         
    As of December 31,  
    2002     2003     2004     2005     2006  
 
Balance Sheet Data:
                                       
Cash and cash equivalents and investment securities, available-for-sale
  $          —     $ 19,089     $ 1,674,337     $ 27,647,112     $ 34,413,603  
Working capital (deficit)
          (188,393 )     1,318,246       26,411,688       29,645,294  
Total assets
          45,709       1,749,672       28,113,629       36,809,984  
Redeemable convertible preferred stock
                10,927,533       45,866,396       45,896,934  
Deficit accumulated during the development stage
    (1,300 )     (1,882,386 )     (9,575,722 )     (21,664,292 )     (49,168,004 )
Total stockholders’ equity (deficit)
          (1,877,112 )     (9,536,669 )     (20,576,544 )     (15,846,922 )

46